Reuters logo
BRIEF-ContraVir Pharmaceuticals announces issuance of new U.S. patent for expansion of cyclophilin inhibitor program
August 21, 2017 / 10:15 AM / a month ago

BRIEF-ContraVir Pharmaceuticals announces issuance of new U.S. patent for expansion of cyclophilin inhibitor program

Aug 21 (Reuters) - ContraVir Pharmaceuticals Inc

* ContraVir Pharmaceuticals announces issuance of new US patent for expansion of cyclophilin inhibitor program

* ContraVir Pharmaceuticals - Anticipates CRV431 will be used in conjunction with tenofovir exalidex its lead drug currently in phase 2 clinical trials Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below